首页 | 本学科首页   官方微博 | 高级检索  
     


Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine,BBIBP-CorV: a randomised,double-blind,placebo-controlled,phase 1/2 trial
Authors:Shengli Xia  Yuntao Zhang  Yanxia Wang  Hui Wang  Yunkai Yang  George Fu Gao  Wenjie Tan  Guizhen Wu  Miao Xu  Zhiyong Lou  Weijin Huang  Wenbo Xu  Baoying Huang  Huijuan Wang  Wei Wang  Wei Zhang  Na Li  Zhiqiang Xie  Xiaoming Yang
Affiliation:1. Henan Provincial Center for Disease Control and Prevention, Henan, China;2. Department of Epidemiology and Biostatistics, College of Public Health, Zhengzhou University, Zhengzhou, Henan, China;3. Beijing Institute of Biological Products, Beijing, China;4. Chinese Center for Disease Control and Prevention, Beijing, China;5. National Institute for Food and Drug Control, Beijing, China;6. MOE Key Laboratory of Protein Science & Collaborative Innovation Center of Biotherapy, School of Medicine, Tsinghua University, Beijing, China;7. Beijing Zhongsheng Hengyi Pharmaceutical Technology, Beijing, China
Abstract:
Keywords:
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号